NCT01140633

Brief Summary

Current measures of adherence detect problems weeks to months after they occur. Because the HIV virus rapidly begins replicating and mutating in the absence of effective antiretroviral therapy, treatment failure may develop before an intervention can be deployed. Real-time objective adherence monitoring could redirect efforts from a reactive response to the proactive prevention of treatment failure. Because adherence is so closely associated with viral suppression, accurate adherence monitoring could also strategically limit viral monitoring only to those patients at a defined risk for viral rebound. This observational study is assessing a wireless adherence monitoring device and mobile phone-based adherence data collection among caregivers of children under the age of ten years in Mbarara, Uganda. It involves both quantitative and qualitative measures of the feasibility and acceptability of these measures, as well as circumstances of adherence lapses and other individual and cultural factors affecting adherence. The qualitative data will be used to explore models of adherence behavior, which will likely include the child-caregiver dynamic, the child's mental and physical health, and social support mechanism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 9, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
Last Updated

September 2, 2013

Status Verified

August 1, 2013

Enrollment Period

9 months

First QC Date

June 7, 2010

Last Update Submit

August 30, 2013

Conditions

Keywords

HIV/AIDSpediatricwireless adherence monitoringHIV Infections

Outcome Measures

Primary Outcomes (1)

  • Distribution of adherence

    Distribution of adherence based on wireless adherence monitoring devices and interactive voice response (IVR) or short message service (SMS) self report by caregivers of HIV-infected children under ten years old in Mbarara, Uganda.

    Monthly adherence levels will be determined over the six-month study period.

Secondary Outcomes (2)

  • Feasibility and acceptability of wireless adherence measures

    Assessments will be made a the one-month time point.

  • Model of adherence behavior

    Data collected at baseline and during adherence interruptions will be analyzed at the end of the six-month study period.

Eligibility Criteria

Age1 Year - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

young children receiving HIV antiretroviral therapy in a rural African setting

You may qualify if:

  • age 1 to 10 years
  • HIV-infected, meeting Ugandan criteria for antiretroviral therapy
  • living within 30 km of Mbarara, Uganda

You may not qualify if:

  • lack of mobile-phone reception

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mbarara University Teaching Hospital

Mbarara, Uganda

Location

Biospecimen

Retention: SAMPLES WITH DNA

Plasma samples with HIV viral DNA.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Jessica E Haberer, MD, MS

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant in Medicine

Study Record Dates

First Submitted

June 7, 2010

First Posted

June 9, 2010

Study Start

April 1, 2010

Primary Completion

January 1, 2011

Study Completion

August 1, 2012

Last Updated

September 2, 2013

Record last verified: 2013-08

Locations